Congratulations on your talk on “Spatial proteomic analysis yields insights into the mode of action for our novel AXL/PD-1 Bispecific T-cell Engager therapy in head and neck squamous cell carcinoma” in the “New horizons in cancer immunology and immunotherapy” session at ILANIT/FISEB 2026.
Leave a Reply